{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:28:42Z","timestamp":1791088122521,"version":"4.1.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/mot.0b013e32834c2356","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T23:59:20Z","timestamp":1317772760000},"page":"632-639","source":"Crossref","is-referenced-by-count":31,"title":["Clinical translation of cell transplantation in the brain"],"prefix":"10.1097","volume":"16","author":[{"given":"Stephen B.","family":"Dunnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210218","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinsons disease.","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"R2-12-20210218","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinsons disease.","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-12-20210218","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinsons disease.","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann Neurol"},{"key":"R4-12-20210218","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2967\/jnumed.109.066811","article-title":"Dopamine cell implantation in Parkinsons disease: long-term clinical and 18F-DOPA PET outcomes.","volume":"51","author":"Ma","year":"2010","journal-title":"J Nucl Med"},{"key":"R5-12-20210218","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinsons disease: 5 year follow-up of the CamPaIGN cohort.","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"R6-12-20210218","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/brain\/awp328","article-title":"The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinsons disease.","volume":"133","author":"Grealish","year":"2010","journal-title":"Brain"},{"key":"R7-12-20210218","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2005.11.011","article-title":"The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.","volume":"22","author":"Lane","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R8-12-20210218","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0079-6123(10)84015-4","article-title":"Unraveling the mechanisms underlying graft-induced dyskinesia.","volume":"184","author":"Lane","year":"2010","journal-title":"Prog Brain Res"},{"key":"R9-12-20210218","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/123.7.1365","article-title":"Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinsons disease.","volume":"123","author":"Lee","year":"2000","journal-title":"Brain"},{"key":"R10-12-20210218","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2005.07.002","article-title":"Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.","volume":"21","author":"Maries","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R11-12-20210218","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1002\/mds.22792","article-title":"Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinsons disease.","volume":"25","author":"Carta","year":"2010","journal-title":"Mov Disord"},{"key":"R12-12-20210218","doi-asserted-by":"crossref","first-page":"38ra46","DOI":"10.1126\/scitranslmed.3000976","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinsons patients with neural transplants.","volume":"2","author":"Politis","year":"2010","journal-title":"Sci Transl Med"},{"key":"R13-12-20210218","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/mds.21768","article-title":"Deep brain stimulation in Parkinsons disease following fetal nigral transplantation.","volume":"23","author":"Herzog","year":"2008","journal-title":"Mov Disord"},{"key":"R14-12-20210218","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/mds.23012","article-title":"Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinsons disease.","volume":"25","author":"Li","year":"2010","journal-title":"Mov Disord"},{"key":"R15-12-20210218","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2217\/rme.10.82","article-title":"Cell therapies and Parkinsons disease: where next Interviewed by Emily Culme-Seymour.","volume":"5","author":"Barker","year":"2010","journal-title":"Regen Med"},{"key":"R16-12-20210218","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntingtons disease.","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"key":"R17-12-20210218","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Persistent benefit of foetal neural transplants in patients with Huntingtons disease six years after surgery.","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol"},{"key":"R18-12-20210218","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntingtons disease undergo disease-like neuronal degeneration.","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-12-20210218","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/brain\/awq328","article-title":"Neuronal degeneration in striatal transplants and Huntingtons disease: potential mechanisms and clinical implications.","volume":"134","author":"Cicchetti","year":"2011","journal-title":"Brain"},{"key":"R20-12-20210218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2010.08.031","article-title":"Technical factors that influence neural transplant safety in Huntingtons disease.","volume":"227","author":"Freeman","year":"2011","journal-title":"Exp Neurol"},{"key":"R21-12-20210218","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2009.12.005","article-title":"Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntingtons disease patients after transplantation.","volume":"222","author":"Gallina","year":"2010","journal-title":"Exp Neurol"},{"key":"R22-12-20210218","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3727\/096368910X546580","article-title":"Medical abortion: a more reliable source of tissue for cell replacement therapy.","volume":"20","author":"Kelly","year":"2011","journal-title":"Cell Transplant"},{"key":"R24-12-20210218","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2010.04.037","article-title":"Towards stem cell replacement therapies for Parkinsons disease.","volume":"396","author":"Arenas","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R25-12-20210218","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ydbio.2009.12.017","article-title":"Lmx1a and Lmx1b cooperate with Foxa2 to coordinate the specification of dopaminergic neurons and control of floor plate cell differentiation in the developing mesencephalon.","volume":"339","author":"Nakatani","year":"2010","journal-title":"Dev Biol"},{"key":"R26-12-20210218","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/stem.294","article-title":"Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"R27-12-20210218","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1523\/JNEUROSCI.0860-10.2010","article-title":"Interactions of Wntbeta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.","volume":"30","author":"Tang","year":"2010","journal-title":"J Neurosci"},{"key":"R28-12-20210218","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/stem.510","article-title":"Gli1 is an inducing factor in generating floor plate progenitor cells from human embryonic stem cells.","volume":"28","author":"Denham","year":"2010","journal-title":"Stem Cells"},{"key":"R29-12-20210218","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.1016679108","article-title":"Doublesex and mab-3-related transcription factor 5 promotes midbrain dopaminergic identity in pluripotent stem cells by enforcing a ventral-medial progenitor fate.","volume":"108","author":"Gennet","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-12-20210218","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.stem.2011.04.001","article-title":"Transcription factor-induced lineage selection of stem-cell-derived neural progenitor cells.","volume":"8","author":"Panman","year":"2011","journal-title":"Cell Stem Cell"},{"key":"R31-12-20210218","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-60761-999-4_22","article-title":"Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells.","volume":"698","author":"Trzaska","year":"2011","journal-title":"Methods Mol Biol"},{"key":"R32-12-20210218","doi-asserted-by":"crossref","first-page":"e19025","DOI":"10.1371\/journal.pone.0019025","article-title":"Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.","volume":"6","author":"Khoo","year":"2011","journal-title":"PLoS One"},{"key":"R33-12-20210218","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2010.11.001","article-title":"Bone marrow stromal cells as replacement cells for Parkinsons disease: generation of an anatomical but not functional neuronal phenotype.","volume":"157","author":"Thomas","year":"2011","journal-title":"Transl Res"},{"key":"R34-12-20210218","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainres.2010.05.071","article-title":"Efficacy of tyrosine hydroxylase gene modified neural stem cells derived from bone marrow on Parkinsons disease: a rat model study.","volume":"1346","author":"Zou","year":"2010","journal-title":"Brain Res"},{"key":"R35-12-20210218","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3727\/096368909X479839","article-title":"Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.","volume":"19","author":"Blandini","year":"2010","journal-title":"Cell Transplant"},{"key":"R36-12-20210218","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res"},{"key":"R37-12-20210218","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntingtons disease: Morphological and behavioral outcomes.","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behav Brain Res"},{"key":"R38-12-20210218","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trsl.2010.12.001","article-title":"Looks like a duck, quacks like a duck. Still behaves like a bone marrow stromal cell.","volume":"157","author":"White","year":"2011","journal-title":"Transl Res"},{"key":"R39-12-20210218","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinsons disease.","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl Res"},{"key":"R40-12-20210218","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"R41-12-20210218","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors.","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"R42-12-20210218","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI40553","article-title":"Progress toward the clinical application of patient-specific pluripotent stem cells.","volume":"120","author":"Kiskinis","year":"2010","journal-title":"J Clin Invest"},{"key":"R43-12-20210218","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells.","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"R44-12-20210218","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI45794","article-title":"Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease.","volume":"121","author":"Rhee","year":"2011","journal-title":"J Clin Invest"},{"key":"R45-12-20210218","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1073\/pnas.1105135108","article-title":"Direct conversion of human fibroblasts to dopaminergic neurons.","volume":"108","author":"Pfisterer","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R46-12-20210218","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00702-010-0478-4","article-title":"Cell-based therapy for stroke.","volume":"118","author":"Luo","year":"2011","journal-title":"J Neural Transm"},{"key":"R47-12-20210218","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/brain\/awr094","article-title":"Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain.","volume":"134","author":"Andres","year":"2011","journal-title":"Brain"},{"key":"R48-12-20210218","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/STROKEAHA.110.599282","article-title":"Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke.","volume":"42","author":"Minnerup","year":"2011","journal-title":"Stroke"},{"key":"R50-12-20210218","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients.","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"key":"R51-12-20210218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt0211-95","article-title":"ReNeuron and StemCells get green light for neural stem cell trials.","volume":"29","author":"Mack","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R52-12-20210218","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt0309-213a","article-title":"Geron gets green light for human trial of ES cell-derived product.","volume":"27","author":"Alper","year":"2009","journal-title":"Nat Biotechnol"},{"key":"R53-12-20210218","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/17482961003663555","article-title":"No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS.","volume":"11","author":"Piepers","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"R54-12-20210218","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","article-title":"Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.","volume":"227","author":"Yamout","year":"2010","journal-title":"J Neuroimmunol"},{"key":"R55-12-20210218","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch Neurol"},{"key":"R56-12-20210218","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","article-title":"Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis. A phase I clinical trial.","volume":"223","author":"Mazzini","year":"2010","journal-title":"Exp Neurol"},{"key":"R57-12-20210218","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/14653249.2010.510504","article-title":"Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia.","volume":"13","author":"Alexanian","year":"2011","journal-title":"Cytotherapy"},{"key":"R58-12-20210218","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3727\/096368910X492652","article-title":"Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial.","volume":"19","author":"Chen","year":"2010","journal-title":"Cell Transplant"},{"key":"R59-12-20210218","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1042\/BST0381465","article-title":"Treatments for lysosomal storage disorders.","volume":"38","author":"Lachmann","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"R60-12-20210218","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/14653241003774037","article-title":"Cellular transplants in amyotrophic lateral sclerosis patients: an observational study.","volume":"12","author":"Gamez","year":"2010","journal-title":"Cytotherapy"},{"key":"R61-12-20210218","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14712598.2011.557060","article-title":"Update on stem cell therapy for cerebral palsy.","volume":"11","author":"Carroll","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"R62-12-20210218","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm0510-492","article-title":"Editorial: Regulators must step up stem cell oversight.","volume":"16","year":"2010","journal-title":"Nat Med"},{"key":"R63-12-20210218","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.stem.2010.06.001","article-title":"Patients beware: commercialized stem cell treatments on the web.","volume":"7","author":"Taylor","year":"2010","journal-title":"Cell Stem Cell"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOT.0b013e32834c2356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T23:59:34Z","timestamp":1639007974000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201112000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e32834c2356","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}